Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Alongside its rotavirus shot Rotarix, GSK also makes vaccines for hepatitis A and B, influenza, shingles, measles, mumps and rubella, to name a few—plus, it’s working on COVID-19 vaccines.